VistaGen Therapeutics Inc
VTGN
|
|
|
|
Trading Volume | 16,328,703 |
|
0.00 - 0.00 |
Market Cap Full | $ 2.7M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | - | - | 21.4% | -36.4% |
Q2 | - | - | -20% | -29% |
Q3 | - | - | - | -83% |
Q4 | - | - | - | -31.3% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
- | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | - |
2023 | |||||||||||
151.5 | -32.1 | -29 | 12 | 1.4 | -29.6 | - | - | - | - | - | - |
2022 | |||||||||||
-16.4 | -12.3 | -13.3 | 7.3 | -17.1 | -20.2 | -84.1 | 28.6 | -16.7 | -13.3 | 7.7 | -26.4 |
2021 | |||||||||||
9.3 | 15.8 | -13.2 | 18.8 | 2.4 | 21.6 | -15.4 | 14.1 | -9.7 | -16.6 | -17.9 | 3.7 |
2020 | |||||||||||
11 | -40.7 | 1.9 | - | 0.4 | 19.4 | 76.4 | -24.7 | - | 4.3 | 2.6 | 159 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -1.6 | -0.1 | -0.3 | -0.1 |
Q2 | -0.9 | -0.1 | -0 | -0.1 |
Q3 | -0.7 | -0.1 | -0.1 | -0.1 |
Q4 | 0 | -1.5 | -0.1 | -0.1 |
A | -3.2 | -1.77 | -0.5 | -0.3 |